Cathay Biotech Balance Sheet Health
Financial Health criteria checks 5/6
Cathay Biotech has a total shareholder equity of CN¥14.9B and total debt of CN¥1.7B, which brings its debt-to-equity ratio to 11.3%. Its total assets and total liabilities are CN¥18.6B and CN¥3.8B respectively. Cathay Biotech's EBIT is CN¥202.4M making its interest coverage ratio -1.1. It has cash and short-term investments of CN¥5.0B.
Key information
11.3%
Debt to equity ratio
CN¥1.68b
Debt
Interest coverage ratio | -1.1x |
Cash | CN¥4.99b |
Equity | CN¥14.86b |
Total liabilities | CN¥3.75b |
Total assets | CN¥18.62b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 688065's short term assets (CN¥7.2B) exceed its short term liabilities (CN¥2.8B).
Long Term Liabilities: 688065's short term assets (CN¥7.2B) exceed its long term liabilities (CN¥1.0B).
Debt to Equity History and Analysis
Debt Level: 688065 has more cash than its total debt.
Reducing Debt: 688065's debt to equity ratio has increased from 4.8% to 11.3% over the past 5 years.
Debt Coverage: 688065's debt is well covered by operating cash flow (41.9%).
Interest Coverage: 688065 earns more interest than it pays, so coverage of interest payments is not a concern.